Format

Send to

Choose Destination
J Bras Nefrol. 2018 Jul-Sep;40(3):301-306. doi: 10.1590/2175-8239-JBN-2018-0021. Epub 2018 Jul 10.

The relationship between proton pump inhibitors and renal disease.

[Article in English, Portuguese]

Author information

1
Universidade Federal Fluminense, Programa de Pós-Graduação em Ciências Médicas, Niterói, RJ, Brasil.
2
Universidade Federal Fluminense, Faculdade de Medicina, Niterói, RJ, Brasil.

Abstract

Proton pump inhibitors (PPIs) bind to enzyme H+/K+-ATPase and inhibit its activity in the stomach, thus decreasing the secretion of gastric acid. PPIs may trigger acute interstitial nephritis, a potentially severe adverse event commonly associated with acute kidney injury. Studies have found that prolonged use of PPIs may increase the risk of chronic kidney disease (CKD). The increase in prescription and inadequate use of this class of medication calls for studies on the effects of prolonged PPI therapy on renal function. Therefore, this review aimed to analyze recent studies on the matter and discuss the possible consequences of the long-term use of PPIs on renal function.

PMID:
30010692
DOI:
10.1590/2175-8239-jbn-2018-0021
Free full text

Supplemental Content

Full text links

Icon for Scientific Electronic Library Online
Loading ...
Support Center